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In this study, we examined a colony of 20 beagle dogs in a laboratory animal facility. Mycoplasma was
detected by consensus PCR assay in 1 dog with respiratory and constitutional symptoms. None of the
other dogs were affected. The dog was euthanized and necropsied. In postmortem examinations, gray or
plum-colored gross lesions were found on the lung, most commonly in the apical and cardiac lobes.
Some lesions showed clear demarcation and consolidation. Microscopic examination showed peribronchiolar
lymphoid hyperplasia and interstitial thickening, lesions pathognomonic for mycoplasma pneumonia. To
identify canine Mycoplasma species, we used species-specific PCR reactions for M. arginini, M. canis, M.
cynos,  M. edwardii,  M. felis,  M. gateae,  M. maculosum,  M. molare,  M. opalescens,  M. spumans,
Mycoplasma sp. HRC 689, and M. collis. As the result, we identified Mycoplasma cynos by amplification
of DNA extracted from lung tissue of the laboratory beagle dog with respiratory disease.
Keywords: Mycoplasma, PCR, consensus, Mycoplasma cynos, Beagle, dog
Received 6 February 2012; Revised version received 1 March 2012; Accepted 4 March 2012
Mycoplasmas belong to the class Mollicutes. They are
among the
 smallest free-living microorganisms capable
of autoreplication.
 They are highly fastidious, difficult to
culture,
 and slow growing [1].
 Many species are important
veterinary pathogens and
 cause respiratory infections,
mastitis, conjunctivitis, arthritis,
 and infrequently, abortion
[1]. It has been reported that mycoplasma infections are
highly contagious and are very common in the field of
laboratory animal medicine [2]. It is necessary to
determine the extent of Mycoplasma contamination in
laboratory animal colonies because these organisms are
prevalent in commercial and research animal facilities
[3], and mycoplasma infections in laboratory animals
interfere with the results of biomedical research [4].
Mycoplasmas are thought to be part of the normal
bacterial flora in the upper respiratory tract in dogs [5],
but there have been conflicting reports about the
presence of mycoplasmas in the lower respiratory tract
of healthy dogs. Randolph et al. [6] found that the lungs
of up to 27% of healthy dogs were colonized, but other
authors have failed to replicate those findings [5]. The
role of individual Mycoplasma species in respiratory
infections of dogs is not well understood. [5] M.
bovigenitalium,  M. canis,  M. cynos,  M. edwardii,  M.
feliminutum,  M. gateae, and M. spumans have been
isolated from dogs with respiratory disease [7,8].
Pneumonia in dogs has been reproduced by experimental
endobronchial inoculation with an isolate of M. cynos
that was isolated from a dog with pneumonia, and by
exposure of non-infected dogs to infected dogs [9,10]. In
addition, several cases have been described in which
pure cultures of mycoplasmas were isolated from dogs
with respiratory disease, but species-level typing was not
performed [6,11]. The overall importance and distribution
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of M. cynos, the mechanisms of pathogenicity, and the
nature of the immune response to this pathogen are
currently unknown.
Polymerase chain reaction (PCR) assay has been
reported as an easy and useful method of rapidly screening
large numbers of animals for mycoplasma species [12],
and it can be performed noninvasively with nasal swabs.
However, multiple PCR assays may be required because
of the large number of Mycoplasma species [1].
In this study, we detected mycoplasma in an infected
laboratory dog by genus-specific consensus PCR using
16S ribosomal DNA. Thereafter, Mycoplasma cynos
was identified by a species-specific PCR.
Twenty male Beagle dogs (age, 1 year) were obtained
from the Animal Facilities of the Center for Animal
Resources Development, Wonkwang University, Korea.
The animal experiments in this study were conducted
according to the ethical procedures of Wonkwang
University IACUC. Over the previous 7 days, 1 dog (No.
8) had developed a dry cough, anorexia, vomiting, and
depression. None of the other 19 dogs had symptoms.
All dogs, including No. 8, underwent physical and
laboratory examinations. Abdominal sonography and
radiography did not demonstrate any abnormal lesions.
Nasal swabs were collected from all 20 dogs. Samplings
were performed from the nares with dry unmoistened
swabs. The tip of the swab was inserted into the nares
and rolled 5 times in each nostril. Specimens were
transported and stored at room temperature. Specimens
were processed for PCR analysis within 24 h of
collection. Each swab was put into 2 mL of 0.1 M PBS
buffer, vortexed, and discarded, and the PBS was used
to extract genomic DNA for Mycoplasma consensus
PCR assay.
Dog No. 8 was euthanized and necropsied. During the
necropsy, tissue specimens were collected from the
lungs, and gross and microscopic observations of
pathological lesions were recorded. For Mycoplasma
identification, fresh tissues were submitted for species-
specific PCR analysis.
For histopathological observation, lung tissues were
fixed in 10% neutral buffered formalin. After fixation,
the tissues were embedded in paraffin in the usual
manner. Sections were cut with a thickness of 4 µm,
floated on a water bath, mounted on slides, and stained
with hematoxylin & eosin. After staining, microscopic
examination was conducted.
The lung tissue of dog No. 8 was homogenized and
resuspended in PBS. Then, the lung tissue suspension
and the nasal swab specimens were submitted for DNA
extraction as described previously [13]. Briefly, genomic
DNA was isolated using an AccuPrep Genomic DNA
extraction kit (Bioneer Corporation, Daejeon, Korea)
according to the manufacturer's instructions. The DNA
was eluted in Tris-EDTA buffer (pH 8.0), and an aliquot
was used for PCR amplification. All DNA samples were
stored at −20
oC until the PCR assays were performed.
To screen for mycoplasma infection, we conducted
Mycoplasma consensus PCR with the DNA extracted
from the nasal swab samples, as described previously
[14]. In brief, amplification of the V3 region of the 16S
ribosomal DNA was performed with consensus primers
GC-341F
  (5'-CGCCCGCCGCGCGCGGCGGGCGGG
GCGGGGGCACGGGGGGCCTACGGGAGGCAGC
AG-3') and 534R (5'-ATTACCGCGGCTGCTGG-3') [1].
The template DNA (50 ng) and 20 pmol
 of each primer
were added to a PCR mixture tube (AccuPower PCR
PreMix; Bioneer Corporation) containing 2.5 U of Taq
DNA polymerase,
  250 µM of each deoxynucleoside
triphosphate, 10 mM Tris-HCl
 (pH 8.3), 40 mM KCl,
1.5 mM MgCl2, and the gel loading dye.
 The final
volume was adjusted to 20 µL with distilled water.
 The
reaction mixture was subjected to denaturation at 94
oC
for 5 min, followed by 30 cycles of 95
oC for 1 min, 55
oC
for 45 s, and 72
oC for 1 min and a final extension step
of 72vC for 10 min, and samples were stored at 4
oC until
analysis. Reactions were conducted using My Genie 32
Thermal Block PCR (Bioneer Corporation). Eight
microliters of each sample were mixed with 2 µL of
loading buffer, and electrophoretically separated on 1.2%
agarose gels stained with 0.5 µg/mL ethidium bromide.
DNA bands were observed under ultraviolet light.
To identify canine Mycoplasma species, we used
species-specific PCR reactions for M. arginini, M. canis,
M. cynos,  M. edwardii,  M. felis,  M. gateae,  M.
maculosum, M. molare, M. opalescens, M. spumans, and
Mycoplasma sp. HRC 689. Due to the high similarity of
the 16S rRNA genes of canine Mycoplasma species
[15], species-specific PCR tests for regions identified in
the 16S/23S rRNA intergenic spacer region had been
developed for the Mycoplasma species [16]. PCR
reactions were performed with forward primer (Myc1;
5'-CACCGCCCGTCACACCA-3'), and following reverse
primers: M. arginini (5'-GTTGTATGACCTATTGTTGT
C-3'),  M. canis (5'-CTGTCGGGGTTATCTCGAC-3'),
M. cynos (5'-GATACATAAACACAACATTATAATATMycoplasma cynos identification from laboratory beagle dogs 63
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TG-3'), M. edwardii (5'-CTGTCGGGTTATCATGCGA
C-3'), M. felis (5'-GGACTATTATCAAAAGCACATAA
C-3'),  M. gateae (5'-GTTGTATGACCTATTGTTGTC-
3'),  M. maculosum (5'-CCTATGATTGTTACAGATG-
3'),  M. molare (5'-AGCCTATTGTTTTTGATTTG-3'),
M. opalescens (5'-TAAGCTTTGTAGACCATAA-3'),
M. spumans (5'-GTTGTATGACCTATTGTTGTC-3'),
and  Mycoplasma sp. HRC 689 (5'-CTTGCGACCTA
ACAAGTCC-3') [16]. Also, we conducted species-
specific PCR to detect M. collis with Primer 1 (5'-
AAAAGAAGCTTGAATTATAG-3') and Primer 2 (5'-
ATTAAGAGTCATTTCCTACT-3') [17]. All PCRs
commenced with an initial denaturation at 95
oC for 5
min and were followed by the specific annealing step
and then by final extension at 72
oC for 5 min. PCR
reactions were performed with each 25 pmol of forward
and reverse primers, and template DNA (50 ng) added to
a PCR mixture tube (AccuPower PCR PreMix; Bioneer
Corporation) containing 2.5 U of Taq DNA polymerase,
250 µM of each deoxynucleoside triphosphate, 10 mM
Tris-HCl (pH 8.3), 40 mM KCl, 1.5 mM MgCl2, and the
gel loading dye.
 The final volume was adjusted to 50 µL
with distilled water.
 Reactions were conducted using My
Genie 32 Thermal Block PCR (Bioneer Corporation).
Eight microliters of each sample were mixed with 2 µL
of loading buffer, and electrophoretically separated on
1.2% agarose gels stained with 0.5 µg/mL ethidium
bromide. DNA bands were observed under ultraviolet
light.
Gross lesions that were gray or plum colored were
found on the lung of dog No. 8, most commonly in the
apical and cardiac lobes. Some lesions showed clear
demarcation and consolidation. The microscopic lesions
were confined to the apical and cardiac lobes of lung.
The plum colored and consolidated areas of the infected
lungs corresponded to mild to severe characteristic
perivascular and peribronchiolar lymphomononuclear
nodules of infiltration, often compressing the lumen of
the bronchioles (Figure 1). The bronchial and bronchiolar
epithelium showed a loss of cilia on the epithelial cells
and sloughing of epithelial cells into the airway lumina.
Infiltrating lymphocytes and mononuclear cells were
frequently seen interspersed between epithelial cells.
Edema fluid, neutrophils, and large mononuclear cells
were seen in the lumina of the airways. The lymphoid
nodules were associated with a narrowing of the lumina
of the airways. Peribronchiolar lymphoid hyperplasia
and interstitial thickening, the pathognomonic lesions of
mycoplasma pneumonia, were observed (Figure 1).
A consensus PCR analysis method using 16S ribosomal
DNA was employed to detect mycoplasmas. The 16S
rDNA gene (340 bp) was specifically amplified by PCR
with the Mycoplasma genus-specific primers (GC-341F
and 534R). The target nucleic acid fragments were
specifically amplified by consensus PCR with 16S
ribosomal DNA primers. As a result, mycoplasma was
detected in the nasal swab sample from dog No. 8 by
PCR (Figure 2). We did not detect any mycoplasmas in
the healthy dogs.
To identify the canine Mycoplasma species from the
lung tissue of dog No. 8, Mycoplasma species-specific
PCR reactions were conducted. We identified M. cynos
by positive amplification of a 227-bp DNA strand
(Figure 3). We did not detect amplification during PCR
assays for M. arginini, M. canis, M. edwardii, M. felis,
M. gateae, M. maculosum, M. molared, M. opalescens,
M. spumans, Mycoplasma sp. HRC 689 or M. collis.
Mycoplasmas are recognized agents of respiratory
disease in a wide range of animal species, including
man. Generally, the disease is mild, but it has been
Figure 1. Histopathological findings in the lung of dog No. 8. (A) Peribronchiolar lymphoid hyperplasia and interstitial thickening
lesions. H&E stain, Bar=100 µm, (B) Infiltrating lymphocytes and mononuclear cells in peribronchiolar hyperplasia lesion. H&E
stain, Bar=20 µm64 Sunhwa Hong, Okjin Kim
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shown to predispose the host to more severe secondary
infection and to exacerbate concurrent infections [18].
Naturally occurring mycoplasmosis is an insidious
disease that may significantly impact research in a
variety of disciplines in the field of laboratory animal
medicine, as the organisms may be disseminated widely
in the hosts [2]. Imperceptible infection is known to
affect physiological mechanisms and the immune system,
thereby influencing experimental results obtained with
contaminated animals [19]. It alters both the number and
subpopulation distribution of lymphocytes in the lung
[4] and it induces elevations in NK cell activity,
suppressing humoral antibody response [20] and
enhancing production of TNF, IL-1, IL-6, and
interferons [21].
Mycoplasma infection in laboratory animals interferes
with the results of biomedical research and can threaten
the heath of personnel conducting animal experiments.
A zoonotic M. pneumoniae outbreak was reported in a
group of students who had an infected Syrian gold hamster
family in their classroom [22]. Recently, Mycoplasma
species have been accepted as important emerging and
reemerging pathogens in human and animal diseases
[23]. There are many questions to be answered
concerning  Mycoplasma
  infection in humans and
animals. In the case of laboratory animals, a number of
Mycoplasma species have been identified and found to
be highly prevalent in animal facilities [2]. The monitoring
and control of these mycoplasmas is necessary to ensure
optimal experimental results in laboratory animals.
Bacterial
 culture has been the best method for diagnosing
a bacterial infection. However, the sensitivity of the
culture-isolation method
 is low [12]. Therefore, a culture
is not considered the
 most practical diagnostic tool. PCR
is a
 specific and sensitive molecular method for detecting
mycoplasma DNA, and can supplement other methods.
However, PCR using species-specific primers may
require multiple assays because of the presence of a
number of Mycoplasma  species [1]. In this study,
consensus PCR successfully detected mycoplasma DNA
in a nasal swab specimen. Thus, consensus PCR may be
recommended for monitoring Mycoplasma species in
laboratory animals.
Mycoplasmas have been implicated as potential agents
of canine respiratory disease [8,24]. Some authors also
describe  Mycoplasma collis as a canine mycoplasma
[25]. However, we cannot find any report of M. collis
infection in dogs and reports indicate that this species
was originally isolated from rodents [26]; therefore, this
species may have been mistakenly identified as being of
canine origin. In addition, other publications describe the
isolation of untyped Mycoplasma spp. from dogs [11,
27]. In the past 20 years, work on canine mycoplasmas
has been extremely limited, with only a dozen publications
Figure 2. Amplification of 16S rDNA gene by mycoplasma consensus PCR was confirmed on a 1.2% agarose gel electrophoresis.
Lane P: positive control, N: distilled water, 1~20: Nasal swab sample of No. 1~No. 20 dog
Figure 3. Amplification of DNA extracted from the lung tissue of dog No. 8 with canine Mycoplasma species-specific primers was
confirmed on 1.2% agarose gel electrophoresis. Lane P: positive control, N: distilled water, 1: M. arginini, 2: M. canis, 3: M. cynos,
4: M. edwardii, 5: M. felis, 6: M. gateae, 7: M. maculosum, 8: M. molare, 9: M. opalescens, 10: M. spumans, 11: Mycoplasma sp.
HRC 689, 12: M. collis Mycoplasma cynos identification from laboratory beagle dogs 65
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on mycoplasmas in dogs. M. cynos was isolated from 2
kenneled dogs with pneumonia [9] and was shown to
induce pneumonia with severe inflammation of bronchi
and respiratory tract tissue [8]. To date, there has been
limited information regarding the etiological role of
mycoplasmas in natural canine disease [5,6,8,9].
However, an association between M. cynos isolated from
the lower respiratory tract and the severity of canine
infectious respiratory disease in kenneled dogs has now
been demonstrated [15]. Only M. cynos was significantly
associated with respiratory disease. Mycoplasmas have
been known for some time to modulate host susceptibility
to secondary infections [18,28]. Thus, the presence of
other initiating agents could be suspected and mycoplasma
agents could be involved. M. cynos has been isolated
from dogs with pneumonia [8,9,29] and was particularly
abundant in the most necrotic areas of the lung [29].
Furthermore, M. cynos was the only agent detected in an
outbreak of severe bronchopneumonia in a litter of
young puppies that resulted in several deaths, but was
resolved in the surviving littermates after the administration
of appropriate antibiotics [30]. Experimental endobronchial
inoculation of dogs with M. cynos has produced
localized pneumonia with destruction and loss of the
bronchial epithelial cilia and alveolar infiltration with
neutrophils and macrophages [10], and in our study, M.
cynos was detected in the lung tissue by PCR. It is
known that M. cynos can persist in the lung for up to 3
weeks following infection [10], and that it can also be
isolated from the trachea, conjunctiva, tonsils, and even
kennel aerosols [16,31]. The capacity of M. cynos to
persist in the environment is unknown, but other
Mycoplasma species can survive for weeks to months
outside the host, and the environment could therefore be
a source of infection [32]. Recently, it has been shown
that biofilm formation is important for persistence of
mycoplasmas and may aid environmental survival [33],
and it seems feasible that M. cynos may be able to persist
in the kennel environment as an adherent biofilm layer.
M. cynos was originally isolated from an outbreak of
enzootic pneumonia in kenneled dogs in which 2 healthy
dogs were exposed to an infected litter [9]. In our study,
M. cynos was identified from the lung of dog with
respiratory disease. Infection with M. cynos may have
been preceded or superseded by infection with another
microorganism. A previous study found that a greater
number of bacteria were isolated from dogs with more
severe clinical disease [34], and this may have made
isolation of M. cynos more difficult due to the increased
number of other bacterial colonies growing on the medium.
In such cases, using Mycoplasma species-specific PCR
directly on clinical samples or filtering samples through
a 0.2-µm filter prior to plating may improve the
detection of M. cynos.
In this study, we encountered a laboratory Beagle dog
with respiratory disease and conducted health examinations
on a colony of 20 of Beagle dogs in the laboratory
animal facilities. Mycoplasma was detected in the dog
with respiratory symptoms by consensus PCR assay, and
no mycoplasma was detected in the healthy dogs. The
affected dog was euthanized. The postmortem examination
revealed pathological lesions on the lung that were gray
or plum colored and most commonly present in the
apical and cardiac lobes. Some lesions showed clear
demarcation and consolidation. Microscopic lesions
were confined to the apical and cardiac lobes of the lung.
The plum-colored and consolidated areas of the infected
lungs corresponded to mild to severe characteristic
perivascular and peribronchiolar lymphomononuclear
nodules of infiltration, often compressing the lumen of
the bronchioles. Peribronchiolar lymphoid hyperplasia
and interstitial thickening lesions, which are known as
pathognomonic findings for mycoplasma pneumonia,
were observed. For Mycoplasma species identification,
fresh tissues were submitted for species-specific PCR
analysis, and M. cynos was identified.
Consensus PCR can successfully detect mycoplasma
and has been recommended for monitoring Mycoplasma
species in laboratory animals [14]. In this study,
consensus PCR was used to detect mycoplasma in
laboratory beagle dogs. The results indicate that consensus
PCR may be useful and effective for monitoring
Mycoplasma species in various kinds of laboratory
animals, including rodents and dogs. The application of
consensus PCR before species-specific PCR would be
the best strategy for the detection and identification of
Mycoplasma species.
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